Sector Chart Interpace Biosciences, Inc.

Stocks

IDXGD

US46062X4025

Healthcare Facilities & Services

Delayed OTC Markets 16:39:27 17/09/2026 BST			5-day change	1st Jan Change
6.450 ^USD	0.00%		-1.83%	+4.86%

08-10	Interpace Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-12	Interpace Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Medical & Diagnostic Laboratories

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
INTERPACE BIOSCIENCES, INC.	35.73M	-	-	-	-	-
NATERA, INC.	52.8B					-
LABCORP HOLDINGS INC.	26.17B
SONIC HEALTHCARE LIMITED	6.89B
RADNET, INC.	6.12B			-	-
DR. LAL PATHLABS LIMITED	3.36B